Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice (Q46738149)

24 December 2017

title

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice (English)

1 reference

24 December 2017

author

Radosveta Koldamova

series ordinal

1

1 reference

24 December 2017

Matthias Staufenbiel

series ordinal

2

object named as

Matthias Staufenbiel

1 reference

24 December 2017

author name string

Iliya Lefterov

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

5 October 2005

1 reference

24 December 2017

Journal of Biological Chemistry

published in

1 reference

24 December 2017

volume

280

1 reference

24 December 2017

issue

52

1 reference

24 December 2017

page(s)

43224-43235

1 reference

24 December 2017

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The current status of Alzheimer's disease genetics: what do we tell the patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Cerebral amyloid angiopathy and gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Liver X Receptor Signaling Pathways in Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Differential expression of cholesterol hydroxylases in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The history of iron in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Risk factors for vascular dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Noninfarct vascular dementia and Alzheimer dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Role of perivascular cells and myocytes in vascular amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Atherosclerosis of cerebral arteries in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504513200

21 January 2018

Identifiers

DOI

10.1074/JBC.M504513200

1 reference

24 December 2017

1 reference

24 December 2017